Related Experiment Video
Updated: Jul 4, 2026

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
Hybrid extrachromosomal DNA in HPV-driven cancers.
Benjamin Hafey1,2, Liangqi Xie1,2,3
1Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA.
Hybrid extrachromosomal DNA (ecDNA) forms in HPV-associated cancers, fusing viral and human genes. These structures offer new therapeutic targets for personalized cancer treatment.
Area of Science:
- Oncology
- Virology
- Genetics
Background:
- Extrachromosomal DNA (ecDNA) drives oncogene amplification and tumor heterogeneity in cancers.
- Human papillomavirus (HPV) integration can create hybrid viral-human ecDNA in HPV-associated oropharyngeal cancers (HPVOPC).
Purpose of the Study:
- To review current insights into hybrid ecDNA formation, regulation, and therapeutic potential.
- To explore how understanding hybrid ecDNA can guide precision cancer therapy.
Main Methods:
- Literature review synthesizing recent findings on hybrid ecDNA.
- Analysis of hybrid ecDNA's molecular features and oncogenic functions.
Main Results:
- Hybrid ecDNA fuses viral oncogenes with human sequences, co-amplifying genes and creating novel enhancers.
- These structures exhibit high gene expression, accessible chromatin, and potentiate oncogenic programs.
Conclusions:
- Hybrid ecDNA represents a distinct class of oncogenic elements with unique regulatory mechanisms.
- Targeting hybrid ecDNA may reveal specific vulnerabilities for personalized HPVOPC therapy.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancers Originate from Somatic Mutations in a Single Cell
Mechanisms of Retrovirus-induced Cancers
Induced Pluripotent Stem Cells
Somatic cells are...

